Skip to main content

Table 2 Clinicopathological characteristics of the 10 PDTC and 27 ATC included in the study

From: Comprehensive gene expression analysis for exploring the association between glucose metabolism and differentiation of thyroid cancer

VariablesPDTC/ATCNo. of available data
Gender (M:F)10: 2737
Age (years, mean ± SD)69 ± 13.74 (27–87)37
Histology
 Papillary / Follicular / Tall cell / Other14 / 5 / 5 / 529
 BRAFV600E (Positive:Negative)NA 
Stage
 1 / 2 or 3 / 41 / 5 / 2430
 Recurrence-free survival time (months)10.3 (0.23–223.49)35
  1. PDTC/ATC Poorly-Differentiated Thyroid Cancer/Anaplastic Thyroid Cancer
  2. Data in parentheses are ranges